New MRI technique to evaluate joint inflammation in osteoarthritis
Novel Non-Contrast MRI to Assess Synovitis in Osteoarthritis
This study is testing a new type of MRI that can help see joint inflammation in people with osteoarthritis without using any contrast dye, making it safer for patients, and aims to better understand how this inflammation affects the disease and its treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11076692 on NIH RePORTER |
What this research studies
This research focuses on developing a novel non-contrast MRI method to assess synovitis, which is inflammation of the joint lining, in patients with osteoarthritis (OA). The study aims to improve the ability to visualize and understand the role of synovitis in OA progression and treatment response without the need for contrast agents, which can pose risks for some patients. By utilizing advanced imaging techniques, the research seeks to provide clearer insights into the disease's mechanisms and potentially guide more effective treatment strategies. Patients participating in this research may undergo MRI scans that help identify inflammation in their joints more accurately.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with osteoarthritis, particularly those experiencing knee pain and inflammation.
Not a fit: Patients with osteoarthritis who do not have significant synovitis or those who are not experiencing knee-related symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnosis and management of osteoarthritis, improving patient outcomes and quality of life.
How similar studies have performed: Previous research has shown promise in using advanced MRI techniques for imaging joint conditions, indicating potential for success in this novel approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Kogan, Feliks — Stanford University
- Study coordinator: Kogan, Feliks
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.